L’Oréal contributes to sun safety
This article was originally published in The Rose Sheet
Executive Summary
Women's Dermatologic Society Foundation has received a $1.05 mil. grant from L'Oréal USA to support its WDS Safe in the Sun Campaign, beauty firm announces Feb. 5. "As a national organization, the Women's Dermatologic Society is enthusiastically committed to serving the communities where our members work and live, by reaching out to people of all skin types to promote sun safety - particularly for outdoor sports enthusiasts who face higher risks. We are grateful to L'Oréal USA for their generous support in fulfilling this mission," WDS President Suzanne Connolly, M.D., says in a statement. Grant will allow the society to raise awareness of the importance of sun protection among female athletes and spectators through community outreach at various golf and tennis events in select U.S. cities. Local WDS members will conduct free skin cancer screenings and photo damage assessments at the events and distribute educational materials...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.